Literature DB >> 17337672

Haemolytic disease of the newborn.

Neil A Murray1, Irene A G Roberts.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17337672      PMCID： PMC2675453          DOI： 10.1136/adc.2005.076794

Source DB:  PubMed          Journal:  Arch Dis Child Fetal Neonatal Ed        ISSN： 1359-2998            Impact factor:   5.747


× No keyword cloud information.
  50 in total

1.  A new cause of haemolytic anaemia in the newborn. A description of an unstable fetal haemoglobin: F Poole, alpha2-G-gamma2 130 trptophan yeilds glycine.

Authors:  J P Lee-Potter; R A Deacon-Smith; M J Simpkiss; H Kamuzora; H Lehmann
Journal:  J Clin Pathol       Date:  1975-04       Impact factor: 3.411

2.  Neonatal administration of high-dose intravenous immunoglobulin in rhesus hemolytic disease.

Authors:  L S Voto; H Sexer; G Ferreiro; J Tavosnanska; J Orti; E R Mathet; M Margulies; M Margulies
Journal:  J Perinat Med       Date:  1995       Impact factor: 1.901

Review 3.  Clinical expression and laboratory detection of red blood cell membrane protein mutations.

Authors:  J Palek; P Jarolim
Journal:  Semin Hematol       Date:  1993-10       Impact factor: 3.851

4.  Prenatal determination of fetal RhD type by DNA amplification.

Authors:  P R Bennett; C Le Van Kim; Y Colin; R M Warwick; B Chérif-Zahar; N M Fisk; J P Cartron
Journal:  N Engl J Med       Date:  1993-08-26       Impact factor: 91.245

Review 5.  alpha-Thalassaemia.

Authors:  D R Higgs
Journal:  Baillieres Clin Haematol       Date:  1993-03

6.  Outcomes among newborns with total serum bilirubin levels of 25 mg per deciliter or more.

Authors:  Thomas B Newman; Petra Liljestrand; Rita J Jeremy; Donna M Ferriero; Yvonne W Wu; Esther S Hudes; Gabriel J Escobar
Journal:  N Engl J Med       Date:  2006-05-04       Impact factor: 91.245

7.  Inhibition of erythroid progenitor cells by anti-Kell antibodies in fetal alloimmune anemia.

Authors:  J I Vaughan; M Manning; R M Warwick; E A Letsky; N A Murray; I A Roberts
Journal:  N Engl J Med       Date:  1998-03-19       Impact factor: 91.245

8.  Prediction of the development of neonatal hyperbilirubinemia in ABO incompatibility.

Authors:  J Y Chen; U P Ling
Journal:  Zhonghua Yi Xue Za Zhi (Taipei)       Date:  1994-01

9.  Fetal anaemia due to pyruvate kinase deficiency.

Authors:  F Gilsanz; M A Vega; E Gómez-Castillo; J A Ruiz-Balda; F Omeñaca
Journal:  Arch Dis Child       Date:  1993-11       Impact factor: 3.791

10.  High-dose intravenous immunoglobulin therapy for rhesus haemolytic disease.

Authors:  T Dağoğlu; F Ovali; N Samanci; E Bengisu
Journal:  J Int Med Res       Date:  1995 Jul-Aug       Impact factor: 1.671
View more
  27 in total

1.  Hemolysis and hyperbilirubinemia in antiglobulin positive, direct ABO blood group heterospecific neonates.

Authors:  Michael Kaplan; Cathy Hammerman; Hendrik J Vreman; Ronald J Wong; David K Stevenson
Journal:  J Pediatr       Date:  2010-07-02       Impact factor: 4.406

2.  Early intravenous immunoglobin (two-dose regimen) in the management of severe Rh hemolytic disease of newborn--a prospective randomized controlled trial.

Authors:  Mohsen Saleh Elalfy; Nancy Samir Elbarbary; Heba Wegdan Abaza
Journal:  Eur J Pediatr       Date:  2010-10-06       Impact factor: 3.183

3.  Addressing hemolysis in an infant due to mother-infant ABO blood incompatibility.

Authors:  Sandra Martin; Rebecca N Jerome; Marcia I Epelbaum; Annette M Williams; William Walsh
Journal:  J Med Libr Assoc       Date:  2008-07

4.  Maternal-fetal blood incompatibility and neuromorphologic anomalies in schizophrenia: Preliminary findings.

Authors:  David Freedman; Raymond Deicken; Lawrence S Kegeles; Sophia Vinogradov; Yuanyuan Bao; Alan S Brown
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2011-05-03       Impact factor: 5.067

Review 5.  Facility-based constraints to exchange transfusions for neonatal hyperbilirubinemia in resource-limited settings.

Authors:  Cecilia A Mabogunje; Sarah M Olaifa; Bolajoko O Olusanya
Journal:  World J Clin Pediatr       Date:  2016-05-08

6.  Incidence and risk factors of post-phototherapy neonatal rebound hyperbilirubinemia.

Authors:  Ismail Mohamed Elhawary; Eman Abdel Ghany Abdel Ghany; Walaa Alsharany Aboelhamed; Shahinaz Gamal Eldin Ibrahim
Journal:  World J Pediatr       Date:  2018-02-20       Impact factor: 2.764

7.  ABO Hemolytic Disease of Fetus and Newborn; Still a Diagnostic Dilemma: A Case Report.

Authors:  Vijay Kumawat; Keerti Kulkarni; Manu Goyal; Venkat Lokadas
Journal:  Indian J Hematol Blood Transfus       Date:  2017-02-23       Impact factor: 0.900

8.  Fetal RHD genotyping by analysis of maternal plasma in a mixed population.

Authors:  Daphne R T Amaral; Débora C Credidio; Jordão Pellegrino; Lilian Castilho
Journal:  J Clin Lab Anal       Date:  2011       Impact factor: 2.352

9.  Exchange Transfusion for Severe Neonatal Hyperbilirubinemia: 17 Years' Experience from Vojvodina, Serbia.

Authors:  Nevenka Bujandric; Jasmina Grujic
Journal:  Indian J Hematol Blood Transfus       Date:  2015-04-02       Impact factor: 0.900

Review 10.  Disorders of the fetomaternal unit: hematologic manifestations in the fetus and neonate.

Authors:  L Vandy Black; Akhil Maheshwari
Journal:  Semin Perinatol       Date:  2009-02       Impact factor: 3.300
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.